Exelixis | Capitalização De Mercado

Market Capitalization Alterar Data
Acadia Pharmaceuticals USD 5.14B 1.73B 2023-12
Agios Pharmaceuticals USD 1.25B 135M 2023-12
Akebia Therapeutics USD 215M 45M 2023-09
Amgen USD 154.14B 10.38B 2023-12
AstraZeneca GBP 164.29B 7.78B 2023-12
Bayer EUR 33.04B 11.61B 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Cytokinetics USD 8.19B 5.36B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
Exelixis USD 7.46B 503M 2023-12
Genmab DKK 142.73B 22.97B 2023-12
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Merck USD 314.33B 38.07B 2024-03
Moderna USD 40.08B 2.16B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Takeda JPY 6.42T 928.65B 2023-12
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
Xencor USD 1.37B 81M 2024-03



Exelixis Capitalização De Mercado - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.